R. Araujo-Castillo

发表

Índice HOMA-IR como predictor de reducción de exceso de peso en pacientes con índice de masa corporal (IMC) ≥ 35 kg/m2 sometidos a gastrectomía vertical

A. Piscoya, Cristina Casas-Tapia, R. Araujo-Castillo, 2020 .

Higher HOMA-IR Index Is Associated With Increased Excess Weight Loss in Patients With BMI ≥ 35 kg/m2 After Vertical Gastrectomy

A. Piscoya, Cristina Casas-Tapia, R. Araujo-Castillo, 2020 .

Statistical analyses in disease surveillance systems

D. Blazes, E. Sedyaningsih, R. Larasati, 2008, BMC proceedings.

High anti-SARS-CoV-2 antibody seroconversion rates before the second wave in Manaus, Brazil, and the protective effect of social behavior measures: Results from the DETECTCoV-19 cohort.

C. Ganoza, B. Albuquerque, E. Assunção, 2021 .

TITLE: Real-world effectiveness of hydroxychloroquine, azithromycin, and ivermectin among hospitalized COVID-19 patients: results of a target trial emulation using observational data from a nationwide healthcare system in Peru Short Title: Target trial emulation of effectiveness of hydroxychloroquin

Carlos Culquichicón, Y. Hurtado-Roca, R. Araujo-Castillo, 2020 .

Efficacy and safety of convalescent plasma versus standard care in hospitalized patients with COVID-19 from the Peruvian Social Security Health System: open-label, randomized, controlled clinical trial

J. L. Maguiña, Y. Hurtado-Roca, R. Araujo-Castillo, 2022, medRxiv.

Influence of comorbidity on hospital outcomes among patients with COVID-19 using electronic records from a nationwide Healthcare System in Peru

Y. Hurtado-Roca, R. Araujo-Castillo, P. Soto-Becerra, 2021 .

Immunogenicity and reactogenicity of a third dose of BNT162b2 vaccine for COVID-19 after a primary regimen with BBIBP-CorV or BNT162b2 vaccines in Lima, Peru

L. Solari, J. Silva-Valencia, R. Araujo-Castillo, 2022, medRxiv.

Genomic surveillance of the Lambda SARS‐CoV‐2 variant in a global phylogenetic context

L. Solari, O. Cáceres, M. Galarza, 2022, Journal of medical virology.

Clinical and parasite species risk factors for pentavalent antimonial treatment failure in cutaneous leishmaniasis in Peru.

F. Chappuis, M. Boelaert, J. Dujardin, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Use of PCR to improve diagnostic yield in an outbreak of cyclosporiasis in Lima, Peru.

D. Blazes, R. Gilman, C. C. Mundaca, 2008, Transactions of the Royal Society of Tropical Medicine and Hygiene.

SARS-CoV-2 seroprevalence and associated factors in Manaus, Brazil: baseline results from the DETECTCoV-19 cohort study

C. Ganoza, Pedro Elias de Souza, T. N. B. D. de Morais, 2021, International Journal of Infectious Diseases.

SARS-CoV-2 Lambda and Gamma variants competition in Peru, a country with high seroprevalence

M. Galarza, Orson Mestanza, N. Rojas-Serrano, 2021, The Lancet Regional Health - Americas.

High anti-SARS-CoV-2 antibody seroconversion rates before the second wave in Manaus, Brazil, and the protective effect of social behaviour measures: results from the prospective DETECTCoV-19 cohort

B. N. Paulino, C. Ganoza, Pedro Elias de Souza, 2021, The Lancet Global Health.

Recurrent Clostridium difficile infection: From colonization to cure.

C. Kelly, T. Theethira, Thimmaiah G. Theethira, 2015, Anaerobe.

Impact of two interventions on timeliness and data quality of an electronic disease surveillance system in a resource limited setting (Peru): a prospective evaluation

David L. Blazes, Moises A. Huaman, Roger V. Araujo-Castillo, 2009, BMC Medical Informatics Decis. Mak..

High prevalence of self‐reported tuberculosis and associated factors in a nation‐wide census among prison inmates in Peru

J. L. Maguiña, R. Araujo-Castillo, Ana L. Salazar‐De La Cuba, 2019, Tropical medicine & international health : TM & IH.

Comments on “Risk of mortality of node-negative, ER/PR/HER2 breast cancer subtypes in T1, T2, and T3 tumors” by Parise CA and Caggiano V, Breast Cancer Res Treat, 2017.

Roger V. Araujo-Castillo, Alejandra F. Pichilingue-Febres, Miguel A. Arias-Linares, 2018, Breast Cancer Research and Treatment.

Burden of disease due to hip, knee, and unspecified osteoarthritis in the Peruvian social health insurance system (EsSalud), 2016

Carlos Culquichicón, R. Araujo-Castillo, Risof Solis Condor, 2020, F1000Research.

Burden of disease due to hip, knee, and unspecified osteoarthritis in the Peruvian social health insurance system (EsSalud), 2016.

Carlos Culquichicón, R. Araujo-Castillo, Risof Solis Condor, 2020, F1000Research.

Norovirus and Infection Control

P. Patel, R. Araujo-Castillo, 2017 .

Challenges in the implementation of an electronic surveillance system in a resource-limited setting: Alerta, in Peru

Miguel F. Fernandez, Joan Neyra, David L Blazes, 2008, BMC proceedings.

Real-world effectiveness of hydroxychloroquine, azithromycin, and ivermectin among hospitalized COVID-19 patients: results of a target trial emulation using observational data from a nationwide healthcare system in Peru

Carlos Culquichicón, Y. Hurtado-Roca, R. Araujo-Castillo, 2020, SSRN Electronic Journal.

Orbital presentation of Rosai–Dorfman disease

M. Fuentes, R. Araujo-Castillo, J. A. Yataco-Vicente, 2018, Archivos de la Sociedad Española de Oftalmología (English Edition).

Recurrent Clostridium difficile infection: From colonization to cure.

C. Kelly, Thimmaiah G. Theethira, R. Araujo-Castillo, 2015, Anaerobe.

Identification of a norovirus outbreak on a hematopoietic stem cell transplant unit and development and implementation of a novel infection prevention algorithm for controlling transmission

G. Snyder, W. Branch-Elliman, S. Wright, 2020, Infection Control & Hospital Epidemiology.

TITLE: Real-World Effectiveness of hydroxychloroquine, azithromycin, and ivermectin among hospitalized COVID-19 patients: Results of a target trial emulation using observational data from a nationwide Healthcare System in Peru Short Title: Target trial emulation of hydroxychloroquine, azithromycin,

Carlos Culquichicón, Y. Hurtado-Roca, R. Araujo-Castillo, 2020 .